C-code goes into effect on July 1, 2017

affording greater opportunity to prostate patients in the United States

 

Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the imminent reimbursement for HIFU prostate tissue ablation with a newly approved C-code.

Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU Registry. The High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry will be a globally accessible, web-based, platform for storing HIFU data on patients treated with Sonablate.

Charlotte, NC (PR Newswire) January 11th, 2017 - SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, reports receipt of 510(k) regulatory clearance to market its latest version of Sonablate® in the United States. Sonablate was the first HIFU device to receive regulatory authorization from the Food and Drug Administration (FDA) for the focused ablation of prostate tissue.

Charlotte, NC (PR Newswire) Oct 5th, 2016,  SonaCare Medical, leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, reports over 40 acquisitions of Sonablate® technology since the device received FDA clearance on October 09, 2015.

Charlotte, NC (PR Newswire) May 5th, 2016, SonaCare Medical, the leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, announces today a marketing alliance with Invivo, a business of Royal Philips (NYSE: PHG; AEX: PHIA) with over 20-years of history as the pioneer of progressive MRI coils, advanced clinical visualization systems, and MRI-compatible interventional devices.

“A fast and accurate fusion is the key to being able to use disease-based information from a diagnostic MRI to drive a focused ultrasound ablation”

CHARLOTTE, N.C., APRIL 26, 2016 – SonaCare Medical, the leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, announces today the execution of a groundbreaking licensing agreement with MIM®, a world leader in the development and deployment of medical imaging and analysis software applications.

Page 1 of 9

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

23 May 2017

C-code goes into effect on July 1, 2017 affording greater opportunity to prostate patients in the United States Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer...

11 April 2017

Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU...